Literature DB >> 3515347

Detection of hepatitis B virus X product using an open reading frame Escherichia coli expression vector.

E Elfassi, W A Haseltine, J L Dienstag.   

Abstract

The genome of the hepatitis B virus (HBV) contains a sequence, designated X, capable of encoding a protein of 154 amino acids. To determine whether the putative protein synthesized from this region is antigenic, we examined the sera of HBV-infected patients for the ability to react with a hybrid protein that contained 133 amino acids encoded by the X region and portions of the bacterial ompF and beta-galactosidase genes. Some HBV-positive sera tested contained antibodies that specifically recognized the hybrid protein. All sera were from patients diagnosed as suffering from chronic active hepatitis. We conclude that the X region of HBV encodes a protein and that this protein is antigenic in some patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3515347      PMCID: PMC323263          DOI: 10.1073/pnas.83.7.2219

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  DNA of a human hepatitis B virus candidate.

Authors:  W S Robinson; D A Clayton; R L Greenman
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

2.  Biology of hepatitis B virus.

Authors:  P Tiollais; P Charnay; G N Vyas
Journal:  Science       Date:  1981-07-24       Impact factor: 47.728

3.  Effects on free recall and recognition of transforming visually presented words and pictures into trace or imagery form.

Authors:  C A Joseph; C R Joseph; C Beasley
Journal:  J Gen Psychol       Date:  1982-01

4.  Hepatitis B virus contains protein attached to the 5' terminus of its complete DNA strand.

Authors:  W H Gerlich; W S Robinson
Journal:  Cell       Date:  1980-10       Impact factor: 41.582

5.  Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma.

Authors:  C Brechot; C Pourcel; A Louise; B Rain; P Tiollais
Journal:  Nature       Date:  1980-07-31       Impact factor: 49.962

6.  Integration of hepatitis B virus sequences and their expression in a human hepatoma cell.

Authors:  J C Edman; P Gray; P Valenzuela; L B Rall; W J Rutter
Journal:  Nature       Date:  1980-07-31       Impact factor: 49.962

7.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.

Authors:  F Galibert; E Mandart; F Fitoussi; P Tiollais; P Charnay
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

8.  Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA.

Authors:  M F Dubois; C Pourcel; S Rousset; C Chany; P Tiollais
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

9.  Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomas.

Authors:  D A Shafritz; M C Kew
Journal:  Hepatology       Date:  1981 Jan-Feb       Impact factor: 17.425

10.  The HBV HBX gene expressed in E. coli is recognised by sera from hepatitis patients.

Authors:  A Kay; E Mandart; C Trepo; F Galibert
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

View more
  13 in total

Review 1.  Viral hepatitis.

Authors:  J Y Lau; G J Alexander; A Alberti
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

2.  X-region-specific transcript in mammalian hepatitis B virus-infected liver.

Authors:  S Kaneko; R H Miller
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

3.  Antibodies to hepatitis B virus x-protein in sera of patients with acute and chronic active hepatitis.

Authors:  R Abraham; H W Doerr; W Braun; M Stemler; H Will; G Hess; C H Schröder
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

4.  Properties of the human hepatitis B virus enhancer: position effects and cell-type nonspecificity.

Authors:  J L Vannice; A D Levinson
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

5.  Frequent detection of antibodies to hepatitis B virus x-protein in acute, chronic and resolved infections.

Authors:  J Hess; M Stemler; H Will; C H Schröder; J Kühn; R Braun
Journal:  Med Microbiol Immunol       Date:  1988       Impact factor: 3.402

6.  Mapping of B-cell epitopes of the human hepatitis B virus X protein.

Authors:  M Stemler; T Weimer; Z X Tu; D F Wan; M Levrero; C Jung; G R Pape; H Will
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma.

Authors:  Guang-Yuh Hwang; Chuang-Yu Lin; Li-Mei Huang; Yan-Hsiung Wang; Jing-Chyi Wang; Ching-Ting Hsu; Sheng-Shun Yang; Cheng-Chung Wu
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

8.  Hepatitis B virus X protein transactivates the long terminal repeats of human immunodeficiency virus types 1 and 2.

Authors:  M Levrero; C Balsano; G Natoli; M L Avantaggiati; E Elfassi
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

Review 9.  Hepatitis B virus infection and primary hepatocellular carcinoma.

Authors:  M Feitelson
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

10.  Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C.

Authors:  R Lucito; R J Schneider
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.